Frontiers in Immunology (Dec 2018)
How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
- Valerio Nardone,
- Pierpaolo Pastina,
- Rocco Giannicola,
- Rita Agostino,
- Stefania Croci,
- Paolo Tini,
- Paolo Tini,
- Luigi Pirtoli,
- Antonio Giordano,
- Antonio Giordano,
- Pierosandro Tagliaferri,
- Pierosandro Tagliaferri,
- Pierpaolo Correale
Affiliations
- Valerio Nardone
- Radiation Oncology Unit, University Hospital of Siena, Siena, Italy
- Pierpaolo Pastina
- Radiation Oncology Unit, University Hospital of Siena, Siena, Italy
- Rocco Giannicola
- Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy
- Rita Agostino
- Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy
- Stefania Croci
- Radiation Oncology Unit, University Hospital of Siena, Siena, Italy
- Paolo Tini
- Radiation Oncology Unit, University Hospital of Siena, Siena, Italy
- Paolo Tini
- Sbarro Health Research Organization, Temple University, Philadelphia, PA, United States
- Luigi Pirtoli
- Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, United States
- Antonio Giordano
- Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, United States
- Antonio Giordano
- Department of Medicine, Surgery and Neurosciences University of Siena, Siena, Italy
- Pierosandro Tagliaferri
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy
- Pierosandro Tagliaferri
- Medical Oncology Unit, Azienda Ospedaliero – Universitaria “Mater Domini”, Catanzaro, Italy
- Pierpaolo Correale
- Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy
- DOI
- https://doi.org/10.3389/fimmu.2018.02941
- Journal volume & issue
-
Vol. 9
Abstract
No abstracts available.Keywords